We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Lunit Unveils AI-Based Mammography Solution at RSNA 2018

By HospiMedica International staff writers
Posted on 26 Nov 2018
Print article
Image: The Lunit INSIGHT for Mammography is expected to increase the cancer detection rate of radiologists by 10% when used as a second reader (Photo courtesy of Lunit).
Image: The Lunit INSIGHT for Mammography is expected to increase the cancer detection rate of radiologists by 10% when used as a second reader (Photo courtesy of Lunit).
Lunit (Seoul, South Korea), a medical artificial intelligence (AI) software company, showcased its newest AI solution for breast cancer—Lunit INSIGHT for Mammography— at this year's gathering of Radiological Society North America (RSNA), which was held on November 25-30 at McCormick Place in Chicago, Ill., USA.

Lunit, abbreviated from "learning unit," is focused on developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep learning technology. The company’s mission is to empower physicians with clinically actionable insights that foster accurate and cost-efficient diagnosis and treatment through unprecedented AI-powered imaging biomarkers with cutting-edge, world-leading accuracy.

Lunit's newest AI software, Lunit INSIGHT for Mammography delivers an accuracy of 97% in detecting malignant lesions, which is expected to increase the cancer detection rate of radiologists by 10% when used as a second reader. The company also claims that its AI solution can enable general radiologists to perform at a specialist level, providing solutions to health facilities that experience strains with lack of specialists. It also aims to decrease recall rate and as a result, save medical costs that are being wasted every year.

At RSNA 2018, the company also showcased Lunit INSIGHT for Chest Radiography, which has been tested in more than 1.5 million cases from more than 70 countries since being launched during last year's RSNA. With an accuracy level of 97-99%, it detects major chest abnormalities including nodules, consolidation, pneumothorax, etc. The CAD-based solution is also being integrated into the worklist for prioritization, in which positive cases may be read first in order to decrease turnaround time and increase overall reading productivity.

Lunit's proprietary AI technology has been trained with vast quality medical data to ensure high accuracy levels. The company’s AI has been trained with over 200,000 chest X-ray cases and 200,000 mammogram cases, out of which 50,000 cases were biopsy-proven malignant cases.

Lunit also presented six abstracts during RSNA 2018, consisting mainly of its latest findings and studies based on its AI technology in medical imaging such as mammography and chest radiography. Lunit’s new CEO Brandon Suh was on stage at Machine Learning Theater to give a presentation titled, “From AI-powered Diagnostic Support Tools to Imaging Biomarkers: Aiming Beyond Human-Level Accuracy,” which provided an overview of the company’s recent achievements and future developments.

Related Links:
Lunit
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Examination Table
Powerline Backrest Top

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.